BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38496564)

  • 1. Combinatorial
    Hebert JD; Tang YJ; Andrejka L; Lopez SS; Petrov DA; Boross G; Winslow MM
    bioRxiv; 2024 Mar; ():. PubMed ID: 38496564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response
    Foggetti G; Li C; Cai H; Hellyer JA; Lin WY; Ayeni D; Hastings K; Choi J; Wurtz A; Andrejka L; Maghini DG; Rashleigh N; Levy S; Homer R; Gettinger SN; Diehn M; Wakelee HA; Petrov DA; Winslow MM; Politi K
    Cancer Discov; 2021 Jul; 11(7):1736-1753. PubMed ID: 33707235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma.
    Yousefi M; Andrejka L; Winslow MM; Petrov DA; Boross G
    bioRxiv; 2023 Feb; ():. PubMed ID: 36778226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma.
    Yousefi M; Andrejka L; Szamecz M; Winslow MM; Petrov DA; Boross G
    Proc Natl Acad Sci U S A; 2023 Sep; 120(38):e2303224120. PubMed ID: 37695905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS-Driven Lung Cancer.
    Cai H; Chew SK; Li C; Tsai MK; Andrejka L; Murray CW; Hughes NW; Shuldiner EG; Ashkin EL; Tang R; Hung KL; Chen LC; Lee SYC; Yousefi M; Lin WY; Kunder CA; Cong L; McFarland CD; Petrov DA; Swanton C; Winslow MM
    Cancer Discov; 2021 Jul; 11(7):1754-1773. PubMed ID: 33608386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis.
    To MD; Rosario RD; Westcott PM; Banta KL; Balmain A
    Oncogene; 2013 Aug; 32(34):4028-33. PubMed ID: 22945650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nullifying the CDKN2AB locus promotes mutant K-ras lung tumorigenesis.
    Schuster K; Venkateswaran N; Rabellino A; Girard L; Peña-Llopis S; Scaglioni PP
    Mol Cancer Res; 2014 Jun; 12(6):912-23. PubMed ID: 24618618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Molecular Characteristics of NF1-Mutant Lung Cancer.
    Redig AJ; Capelletti M; Dahlberg SE; Sholl LM; Mach S; Fontes C; Shi Y; Chalasani P; Jänne PA
    Clin Cancer Res; 2016 Jul; 22(13):3148-56. PubMed ID: 26861459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma.
    McFadden DG; Politi K; Bhutkar A; Chen FK; Song X; Pirun M; Santiago PM; Kim-Kiselak C; Platt JT; Lee E; Hodges E; Rosebrock AP; Bronson RT; Socci ND; Hannon GJ; Jacks T; Varmus H
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6409-E6417. PubMed ID: 27702896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminishing-returns epistasis among random beneficial mutations in a multicellular fungus.
    Schoustra S; Hwang S; Krug J; de Visser JA
    Proc Biol Sci; 2016 Aug; 283(1837):. PubMed ID: 27559062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer.
    Murray CW; Brady JJ; Han M; Cai H; Tsai MK; Pierce SE; Cheng R; Demeter J; Feldser DM; Jackson PK; Shackelford DB; Winslow MM
    Nat Commun; 2022 Feb; 13(1):1090. PubMed ID: 35228570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Widespread epistasis among beneficial genetic variants revealed by high-throughput genome editing.
    Ang RML; Chen SA; Kern AF; Xie Y; Fraser HB
    Cell Genom; 2023 Apr; 3(4):100260. PubMed ID: 37082144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLC.
    Zhang H; Nabel CS; Li D; O'Connor RÍ; Crosby CR; Chang SM; Hao Y; Stanley R; Sahu S; Levin DS; Chen T; Tang S; Huang HY; Meynardie M; Stephens J; Sherman F; Chafitz A; Costelloe N; Rodrigues DA; Fogarty H; Kiernan MG; Cronin F; Papadopoulos E; Ploszaj M; Weerasekara V; Deng J; Kiely P; Bardeesy N; Vander Heiden MG; Chonghaile TN; Dowling CM; Wong KK
    J Thorac Oncol; 2023 Jul; 18(7):882-895. PubMed ID: 36958689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras.
    Kawaguchi Y; Hinoi T; Saito Y; Adachi T; Miguchi M; Niitsu H; Sasada T; Shimomura M; Egi H; Oka S; Tanaka S; Chayama K; Sentani K; Oue N; Yasui W; Ohdan H
    J Gastroenterol; 2016 May; 51(5):447-57. PubMed ID: 26361962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminishing returns from beneficial mutations and pervasive epistasis shape the fitness landscape for rifampicin resistance in Pseudomonas aeruginosa.
    MacLean RC; Perron GG; Gardner A
    Genetics; 2010 Dec; 186(4):1345-54. PubMed ID: 20876562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative epistasis between beneficial mutations in an evolving bacterial population.
    Khan AI; Dinh DM; Schneider D; Lenski RE; Cooper TF
    Science; 2011 Jun; 332(6034):1193-6. PubMed ID: 21636772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinatorial CRISPR/Cas9 Screening Reveals Epistatic Networks of Interacting Tumor Suppressor Genes and Therapeutic Targets in Human Breast Cancer.
    Zhao X; Li J; Liu Z; Powers S
    Cancer Res; 2021 Dec; 81(24):6090-6105. PubMed ID: 34561273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETS1 regulates Twist1 transcription in a Kras
    Millien G; Cao Y; O'Hara CJ; Tagne JB; Hinds A; Williams MC; Ramirez MI; Kathuria H
    Clin Exp Metastasis; 2018 Mar; 35(3):149-165. PubMed ID: 29909489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive Phenotypes Underlie Epistasis of Fitness Effects.
    Sackman AM; Rokyta DR
    Genetics; 2018 Jan; 208(1):339-348. PubMed ID: 29113978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The consistency of beneficial fitness effects of mutations across diverse genetic backgrounds.
    Pearson VM; Miller CR; Rokyta DR
    PLoS One; 2012; 7(8):e43864. PubMed ID: 22937113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.